US to partially stop funding mRNA vaccines

The US government is waging a battle against messenger RNA, despite promising research into various diseases. This technology was thrust into the spotlight during the Covid-19 pandemic, during which it enabled the rapid commercialization of effective vaccines.

Far from the time when Donald Trump, in December 2020 – at the end of his first term in the White House – praised the effectiveness and speed of development of this technology, which he described as a "miracle of modern times", the American Secretary of Health, Robert Kennedy Jr, led a full-scale attack against it on Tuesday, August 5.

Known for his "vaccine skepticism," he announced the cessation of funding for projects related to the research and development of mRNA vaccines supported by the American Biomedical Research and Development Authority (BARDA), the government agency for preparing for public health emergencies and pandemic threats.

"We've looked at the science, listened to the experts, and we're taking action," Kennedy said in a statement, adding that "the data shows these vaccines are not effective in protecting against upper respiratory infections like Covid-19 and the flu." In a video posted on the social network X, he even claimed that "mRNA technology poses more risks than benefits for these respiratory viruses."

You have 77.23% of this article left to read. The rest is reserved for subscribers.